Outcomes From Real-World Data on Intraoperative Electronic Radiotherapy for the Treatment of Early-Stage Breast Cancer: Long-Term Recurrence and Survival Outcomes From a Single Center

被引:0
|
作者
de la Mata, Dolores [1 ]
Santiago-Concha, Bernardino Gabriel [1 ]
Bargallo-Rocha, Juan Enrique [2 ]
Robles-Vidal, Carlos Daniel [2 ]
Gomez-Pue, Daniella [2 ]
Castorena-Roji, Gerardo [2 ]
Hinojosa-Gomez, Jose [1 ]
Flores-Vazquez, Fabiola [1 ]
Blake-Cerda, Monika [1 ]
Enriquez-Barrera, Mario [1 ]
Maffuz-Aziz, Antonio [2 ]
机构
[1] Ctr Med ABC, Dept Radiat Oncol, Mexico City, Mexico
[2] Ctr Med ABC, Dept Oncol Surg Gynecol Surg, Mexico City, Mexico
关键词
IORT; Lumpectomy; Mastectomy-free; Overall survival; Targeted radiotherapy; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; LUMPECTOMY; MASTECTOMY; TRIAL; ELIOT; NODE;
D O I
10.1155/2024/6207762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study is aimed at investigating the 10-year outcomes of intraoperative radiotherapy (IORT) in Mexican women with early breast cancer (EBC) treated at the Centro Medico ABC, Mexico City.Methods: A cohort study included women with early-stage invasive ductal carcinoma aged >= 45 years without prior oncologic treatment, tumor size <= 3.5 cm, cN0M0, positive hormone receptors, margins >= 2 mm, negative sentinel lymph nodes, and no extensive lymphovascular invasion. IORT was administered at 20 Gy for 20-30 min after a lumpectomy. Follow-up extended over 10 years and included clinical examinations every 6 months for the first 18 months, followed by annual mammograms and conventional examinations. Patients out of the criteria were excluded from this study because they were referred for additional surgery and/or whole-breast radiation therapy.Results: The study involved 238 patients with an average age of 61.1 years. The mean tumor size was 12 mm, and the percentages of lymphatic invasion, positive hormone receptors, and HER2/neu overexpression were 12.6%, 90.8%, and 2.1%, respectively. The median follow-up was 66.6 months (range: 1-126 months), and the overall survival and mastectomy-free rate reached 95.7% and 90%, respectively. Thirteen patients showed side effects; four recurrences were recorded, of which 50% were out-field relapses. The 5-year Kaplan-Meier probability of local relapses, mastectomy-free, and overall survival reached 97.5%, 100%, and 98%, respectively.Conclusions: This is the first 10-year report about the effect of IORT on Mexican women with EBC in the early stages. Strict adherence to the selection criteria in this study resulted in low rates of side effects, mortality, and local recurrences, demonstrating that IORT is an effective treatment alternative for patients with EBC. Studies with a longer follow-up period should be performed, as recurrences can occur in the long term.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Updated Outcomes from a Single-Institution Experience
    Halima, Ahmed
    Fane, Lauren
    Parker, Sean
    Obi, Elizabeth
    Fleming-Hall, Erica
    Gentle, Corey
    Cherian, Sheen
    Valente, Stephanie
    Al-Hilli, Zahraa
    Tendulkar, Rahul
    Shah, Chirag
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 931 - 935
  • [22] Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Updated Outcomes from a Single-Institution Experience
    Ahmed Halima
    Lauren Fane
    Sean Parker
    Elizabeth Obi
    Erica Fleming-Hall
    Corey Gentle
    Sheen Cherian
    Stephanie Valente
    Zahraa Al-Hilli
    Rahul Tendulkar
    Chirag Shah
    Annals of Surgical Oncology, 2024, 31 : 931 - 935
  • [23] Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer
    McDonald, Catherine
    Squires, Rebecca
    Gormley, Mark
    Langdon, Ryan
    Archer, Ann
    Ball, Jessica
    Gullick, Georgina
    Caws, Chloe
    Boardman, John
    Mohan, Vivek
    Bahl, Amit
    Jenkins, Jessica
    Comins, Charles
    Gibbs, Lara
    Braybrooke, Jeremy
    Robinson, Timothy
    CANCER RESEARCH, 2021, 81 (04)
  • [24] Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study
    Jitwatcharakomol, Tanun
    Setakornnukul, Jiraporn
    Chuthatisith, Suebwong
    Ratanawichitrasin, Adune
    Petsuksiri, Janjira
    Sirima, Naponwan
    Thephamongkhol, Kullathorn
    BREAST CANCER, 2024, 31 (06) : 1092 - 1100
  • [25] Long-Term Economic and Employment Outcomes Among Partners of Women With Early-Stage Breast Cancer
    Veenstra, Christine M.
    Wollner, Lauren P.
    Jags, Reshma
    Abrahamse, Paul
    Griggs, Jennifer, I
    Bradley, Cathy J.
    Hawley, Sarah T.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (11) : 754 - +
  • [26] Long-Term Outcomes With Teduglutide From a Single Center
    Puello, Frances
    Wall, Elizabeth
    Herlitz, Jean
    Lozano, Edward S.
    Semrad, Carol
    Micic, Dejan
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2021, 45 (02) : 318 - 322
  • [27] Real-World Outcomes of Ixazomib in the Treatment of Multiple Myeloma from a Single Center in China
    Sui, Weiwei
    An, Gang
    Deng, Shuhui
    Xu, Yan
    Hao, Mu
    Fu Mingwei
    Wang, Tingyu
    Yi, Shuhua
    Zhao, Yaozhong
    Zou, Dehui
    Li, Zengjun
    Qiu, Lugui
    BLOOD, 2019, 134
  • [28] Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer
    Connors, Casey
    Valente, Stephanie A.
    ElSherif, Ayat
    Escobar, Paula
    Chichura, Anna
    Kopicky, Lauren
    Roesch, Erin
    Ritner, Julie
    Mcintire, Patrick
    Wu, Yueqi
    Tu, Chao
    Lang, Julie E.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 912 - 921
  • [29] Real-world outcomes in patients receiving neoadjuvant chemotherapy for early-stage triple-negative breast cancer
    Rhodes, Whitney C.
    Gautam, Santosh
    Haiderali, Amin
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Evaluation of long-term outcomes of icatibant using real-world data from the Icatibant Outcome Survey
    Laffan, J.
    Longhurst, H.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Maurer, M.
    Fabien, V.
    Andresen, I.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (12): : 1887 - 1887